» Articles » PMID: 37255627

Evaluation of a Pain Management Program for Patients with Median Arcuate Ligament Syndrome

Overview
Journal SAGE Open Med
Publisher Sage Publications
Specialty General Medicine
Date 2023 May 31
PMID 37255627
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Median arcuate ligament syndrome is a complex disorder potentially caused by variation in the position of the median arcuate ligament. Symptomology involves chronic abdominal pain, nausea, and malnourishment. Pain management modalities and short-term outcomes for patients undergoing operative surgery for median arcuate ligament syndrome have yet to be fully evaluated. Our hospital implemented a pain management consultation program in 2017 focused on perioperative pain management. The objective of this study is to assess if the introduction of a pain management consultation program concurrent with median arcuate ligament syndrome surgery impacts patient outcomes and post-operative pain management strategies in these patients.

Methods: De-identified data was collected retrospectively from our hospital's electronic medical records system, identifying median arcuate ligament syndrome patients and using International Classification of Diseases (ICD) and Current Procedural Terminology (CPT) codes from September 2017 to August 2021. Patients were grouped into the "consultation" cohort if they had scheduled and attended a pre-operative pain consultation. Pre-operative and discharge medications, pain scores, and demographics were collected to evaluate if the initiative impacted outcomes.

Results: Median arcuate ligament syndrome patients who had a pre-operative pain management consultation had higher rates of pre-operative opioid (35.5%;  = 0.01) and non-opioid use (60.7%;  < 0.001). Patients without a pre-operative consultation that did not use opioids pre-operatively were more likely to be discharged on one or more opioids. Differences were also found for psychiatric medication at discharge ( < 0.001) with patients receiving pain consultation indicating higher percentages of use.

Conclusion: Special consideration on prescribing pain medication should be part of discharge planning for median arcuate ligament syndrome patients. Addition of a pain management consultation can aid in these decisions.

References
1.
Kurteva S, Abrahamowicz M, Gomes T, Tamblyn R . Association of Opioid Consumption Profiles After Hospitalization With Risk of Adverse Health Care Events. JAMA Netw Open. 2021; 4(5):e218782. PMC: 8132136. DOI: 10.1001/jamanetworkopen.2021.8782. View

2.
Lawal O, Gold J, Murthy A, Ruchi R, Bavry E, Hume A . Rate and Risk Factors Associated With Prolonged Opioid Use After Surgery: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020; 3(6):e207367. PMC: 7317603. DOI: 10.1001/jamanetworkopen.2020.7367. View

3.
Romero-Velez G, Barajas-Gamboa J, Pantoja J, Corcelles R, Rodriguez J, Navarrete S . A nationwide analysis of median arcuate ligament release between 2010 and 2020: a NSQIP Study. Surg Endosc. 2022; 37(1):140-147. PMC: 9296109. DOI: 10.1007/s00464-022-09431-3. View

4.
Rodriguez J . Median arcuate ligament syndrome: A clinical dilemma. Cleve Clin J Med. 2021; 88(3):143-144. DOI: 10.3949/ccjm.88a.21001. View

5.
Columbo J, Trus T, Nolan B, Goodney P, Rzucidlo E, Powell R . Contemporary management of median arcuate ligament syndrome provides early symptom improvement. J Vasc Surg. 2015; 62(1):151-6. PMC: 5292272. DOI: 10.1016/j.jvs.2015.01.050. View